Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | +3.25% | +4.16% | +15.53% |
03:10pm | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Evolution of the average Target Price on Achieve Life Sciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Achieve Life Sciences, Inc.
JonesTrading Institutional Services | |
Oppenheimer | |
Lake Street | |
Maxim | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- ACHV Stock
- Consensus Achieve Life Sciences, Inc.